Quantitative MRI on the verge of clinical application

SCIENTIFIC SESSION-Chairs: Christian Enzinger and Alex Rovira

9:00 – 9:10 INTRODUCTION

Ludwig Kappos

9:10 – 9.30 What does qMRI need to tell us about MS neuropathology?”

or “Expectations for quantitative MRI – what do we need to assess?” (Jeroen Geurts)

9:30 – 10:10 T1 relaxometry

T1 mapping inside and outside lesions: all-in-one to measure disease impact and progression? (Pascal Sati)

The real T1 does not exist – and even if it did, we cannot measure it (Hugo Vrenken)

10:00 – 10:10 Discussion

10:10 – 10:50 T2 relaxometry, MWI, MT

Myelin and beyond: why our patients (and us) need quantification now (Mara Rocca)

Myelin – or not Myelin, that is the dilemma (Frederik Barkhof)

10:40 – 10:50 Discussion

10:50 – 11:30 Diffusion

Diffusion-based microstructure in MS: why it should be considered for MS patient´s management (Ahmed Toosy)

Diffusion-based microstructure: reality – or modeling theory? (Claudia Wheeler-Kingshott)

11:20 – 11:30 Discussion

1:30 – 11:45 BREAK

SCIENTIFIC SESSION-Chairs: Nicola de Stefano and Massimo Filippi

11:45 – 12:15 Susceptibility

Quantitative susceptibility imaging in the clinical routine: we need it! (Nikos Evangelou)

The eternal promises (and pitfalls) of susceptibility mapping (Stefan Ropele)

12:15 – 12:25 Discussion

12:25 – 12:55 Perfusion

Perfusion imaging in clinical routine – long time neglected but important (Jens Würfel)

Gad accumulation & spin losses: is that perfusion MRI? (Massimiliano Calabrese)

12:55 – 13:05 Discussion

13:05 – 13:15 qMRI in the clinic – provisional appraisal

Towards clinical decision support in MS with qMRI (Cristina Granziera)

13:15 – 13:30 CLOSING REMARKS

Mara Rocca and Christian Enzinger